US · ACB
Aurora Cannabis Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Edmonton, AB T5J 1Y6
- Website
- auroramj.com
Price · as of 2025-03-31
$3.48
Market cap 217.76M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $16.40 | +371.26% |
| Intrinsic Value(DCF) | $2.29 | -34.2% |
| Graham-Dodd Method(GD) | $6.90 | +98.28% |
| Graham Formula(GF) | $0.70 | -79.89% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | $97.09 | ||||
| 2015 | $23.14 | ||||
| 2016 | $93.50 | $0.00 | $0.00 | ||
| 2017 | $245.32 | $295.31 | $39,871.26 | $37.60 | $0.00 |
| 2018 | $740.40 | $392.19 | $502,722.57 | $206.40 | $2,638.30 |
| 2019 | $729.60 | $485.07 | $0.00 | $0.00 | $0.00 |
| 2020 | $85.10 | $34.04 | $0.00 | $0.00 | $0.00 |
| 2021 | $66.30 | $26.52 | $0.00 | $0.00 | $8.40 |
| 2022 | $15.60 | $6.24 | $0.00 | $0.00 | $71.10 |
| 2023 | $5.30 | $2.16 | $0.97 | $0.00 | $0.00 |
| 2024 | $5.68 | $11.90 | $0.00 | $2.40 | $0.00 |
| 2025 | $5.72 | $22.96 | $1.06 | $6.90 | $0.70 |
AI valuation
Our deep-learning model estimates Aurora Cannabis Inc.'s (ACB) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $16.40
- Current price
- $3.48
- AI upside
- +371.26%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.29
-34.2% upside
Graham-Dodd
$6.90
+98.28% upside
Graham Formula
$0.70
-79.89% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ACB | Aurora Cannabis Inc. | $3.48 | 217.76M | +560% | -34% | +98% | -80% | 27.82 | 0.78 | 1.28 | 6.97 | — | 0.92 | 54.65% | 1.44% | 0.46% | 2.80% | 0.80% | 1.87% | 0.18 | 0.59 | 4.31 | 2.06 | -1.56 | -10223.00% | 2701.00% | -9666.00% | -0.65% | 0.15 | -0.59% | 0.00% | 0.00% | 0.12% | 72.30 | -125.35 | 1.04 | -8.43 |
| ACRS | Aclaris Therapeutics, Inc… | $2.87 | 310.95M | +859% | -54% | — | +777% | -5.76 | 3.63 | 47.81 | -3.46 | — | 3.63 | 73.28% | -975.91% | -829.58% | -50.20% | 2416.55% | -34.10% | 0.00 | — | 5.28 | 5.28 | 0.31 | -6901.00% | -5819.00% | 13383.00% | -12.62% | -1.64 | 1494.19% | 0.00% | 0.00% | 0.00% | -2.92 | -4.72 | 28.46 | -5.14 |
| BIOA | BioAge Labs, Inc. | $22.27 | 798.49M | — | — | — | — | -0.69 | 0.15 | — | 4.33 | — | 0.15 | 0.00% | — | — | -94.98% | 95.18% | -37.02% | 0.03 | -33.04 | 12.86 | 12.76 | 5.04 | -2246.00% | — | 3826.00% | -106.31% | -1.85 | 63.16% | 0.00% | 0.00% | 772.94% | 3.80 | 5.72 | — | 0.23 |
| CGC | Canopy Growth Corporation | $1.12 | 576.26M | +725% | -39% | — | +204% | -0.42 | 0.52 | 0.95 | -0.99 | — | 0.72 | 29.56% | -43.55% | -222.35% | -122.35% | -14.04% | -54.48% | 0.72 | -1.57 | 3.12 | 1.95 | -0.49 | -3709.00% | -947.00% | -3809.00% | -69.30% | -1.76 | -21.21% | 0.00% | 0.00% | 102.99% | -4.03 | -2.67 | 1.76 | -16.18 |
| EDIT | Editas Medicine, Inc. | $2.20 | 214.76M | +883% | +13% | — | +6,172% | -0.60 | 1.05 | 4.38 | 0.40 | -1.40 | 1.05 | 100.00% | -777.22% | -733.72% | -98.10% | 1925.86% | -56.40% | 0.26 | — | 3.75 | 3.71 | 0.41 | 4257.00% | -5864.00% | 6005.00% | -154.71% | -2.72 | 1680.16% | 0.00% | 0.00% | 15.11% | 0.37 | 0.43 | -2.89 | -7.20 |
| HITI | High Tide Inc. | $2.53 | 222.23M | +702% | -58% | — | — | -6.02 | 3.49 | 0.51 | -29.64 | -0.58 | -7.28 | 25.85% | -2.43% | -8.54% | -43.96% | -8.04% | -17.05% | 1.71 | -1.08 | 1.37 | 0.54 | -7.42 | 103761.00% | 1372.00% | -4795.00% | 4.40% | 0.24 | 7.47% | 0.46% | -2.80% | 0.46% | -28.19 | 30.34 | 0.69 | 1.39 |
| IRWD | Ironwood Pharmaceuticals,… | $3.42 | 556.36M | +1,376% | -58% | -88% | — | 24.11 | -10.55 | 1.96 | 5.51 | 0.21 | -10.18 | 99.36% | 40.10% | 8.11% | -13.49% | 62.48% | 6.42% | -3.88 | 3.63 | 1.13 | 1.08 | -0.03 | 1171818.00% | -1572.00% | 2283.00% | 21.93% | 0.52 | 167.05% | 0.00% | 0.00% | 88.68% | 4.85 | 4.54 | 1.95 | 2.60 |
| LFCR | Lifecore Biomedical, Inc. | $7.20 | 269.76M | +1,115% | -61% | — | — | -6.29 | 182.17 | 1.89 | -41.53 | — | -14.53 | 31.27% | -13.38% | -30.04% | -612.08% | -13.25% | -15.70% | 97.92 | -0.79 | 2.84 | 1.72 | -13.91 | -48485.00% | 47.00% | -2490.00% | -5.60% | -0.01 | -10.46% | 0.00% | 0.00% | 1.05% | -21.22 | -26.87 | 2.84 | -0.01 |
| LFMD | LifeMD, Inc. | $2.67 | 128.52M | +1,008% | +2,300% | — | — | -10.27 | -35.07 | 0.91 | -27.43 | — | -9.02 | 88.67% | -7.60% | -8.89% | 1891.64% | 123.73% | -28.61% | -4.58 | -7.40 | 0.81 | 0.72 | 1.49 | -2429.00% | 3927.00% | 677408.00% | 3.11% | 0.29 | -45.81% | 1.61% | -16.60% | 1.61% | -11.30 | 30.53 | 0.86 | -1.05 |
| OGI | Organigram Global Inc. | $1.43 | 193.24M | +1,566% | -48% | -16% | — | -11.89 | 0.84 | 1.58 | -18.57 | — | 1.06 | 3.67% | -34.07% | -9.55% | -7.56% | -15.33% | -5.10% | 0.03 | — | 2.26 | 0.74 | 1.32 | -7083.00% | 1642.00% | 102705.00% | -5.61% | -0.03 | -6.21% | 0.00% | 0.00% | 0.00% | -4.32 | -16.59 | 1.47 | -0.39 |
| TKNO | Alpha Teknova, Inc. | $2.58 | 138.11M | +974% | -63% | — | — | -7.38 | 1.85 | 3.14 | -13.45 | — | 2.24 | 33.17% | -41.90% | -42.59% | -22.83% | -21.20% | -15.52% | 0.22 | -23.91 | 4.58 | 1.40 | -0.91 | -4386.00% | 735.00% | -3170.00% | -7.25% | -1.07 | -11.53% | 0.00% | 0.00% | 13.58% | -8.04 | -14.79 | 3.37 | 0.52 |
About Aurora Cannabis Inc.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
- CEO
- Miguel Martin
- Employees
- 1.07K
- Beta
- 1.36
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.29 ÷ $3.48) − 1 = -34.2% (DCF, example).